These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4399780)

  • 1. Drug metabolism by an acetone powder from rat hepatic microsomes.
    Leber P; Bousquet WF
    Life Sci I; 1971 Sep; 10(18):1037-43. PubMed ID: 4399780
    [No Abstract]   [Full Text] [Related]  

  • 2. The intracellular localization of 9 -tetrahydrocannabinol in liver and its effects on drug metabolism in vitro.
    Dingell JV; Miller KW; Heath EC; Klausner HA
    Biochem Pharmacol; 1973 Apr; 22(8):949-58. PubMed ID: 4693827
    [No Abstract]   [Full Text] [Related]  

  • 3. Diphenylhydantoin effect on neonatal and adult rat hepatic drug metabolism.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    J Pharmacol Exp Ther; 1970 Jan; 171(1):127-34. PubMed ID: 5410930
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulation by chlordane of hepatic drug metabolism in the squirrel monkey.
    Cram RL; Juchau MR; Fouts JR
    J Lab Clin Med; 1965 Dec; 66(6):906-11. PubMed ID: 4378995
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of drugs in old rats. I. Activities of NADPH-linked electron transport and drug-metabolizing enzyme systems in liver microsomes of old rats.
    Kato R; Takanaka A
    Jpn J Pharmacol; 1968 Dec; 18(4):381-8. PubMed ID: 4388257
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of iron, riboflavin and iodide deficiencies on hepatic drug-metabolizing enzyme systems.
    Catz CS; Juchau MR; Yaffe SJ
    J Pharmacol Exp Ther; 1970 Aug; 174(2):197-205. PubMed ID: 5451357
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic drug metabolism in vitro in the horse.
    Yeary RA; Gerken D
    Biochem Pharmacol; 1971 Nov; 20(11):3219-21. PubMed ID: 5132124
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of magnesium and some other divalent cations on hepatic microsomal drug metabolism in vitro.
    Peters MA; Fouts JR
    Biochem Pharmacol; 1970 Feb; 19(2):533-44. PubMed ID: 4396251
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the mechanism of sex difference in drug-oxidizing activity of liver microsomes.
    Kato R; Takanaka A; Takayanagi M
    Jpn J Pharmacol; 1968 Dec; 18(4):482-9. PubMed ID: 4388258
    [No Abstract]   [Full Text] [Related]  

  • 10. An approach measurement of the stoichiometric relationship between hepatic microsomal drug metabolism and the oxidation of reduced nicotinamide adenine dinucleotide phosphate.
    Stripp B; Zampaglione N; Hamrick M; Gillette JR
    Mol Pharmacol; 1972 Mar; 8(2):189-96. PubMed ID: 4402003
    [No Abstract]   [Full Text] [Related]  

  • 11. Impairment of hepatic drug metabolism in calcium deficiency.
    Dingell JV; Joiner PD; Hurwitz L
    Biochem Pharmacol; 1966 Jul; 15(7):971-6. PubMed ID: 5967908
    [No Abstract]   [Full Text] [Related]  

  • 12. The diphasic action of halothane on the oxidative metabolism of drugs by the liver. An in-vitro study in the rat.
    Brown BR
    Anesthesiology; 1971 Sep; 35(3):241-6. PubMed ID: 5095536
    [No Abstract]   [Full Text] [Related]  

  • 13. Further studies on the metabolism of drugs by subfractions of hepatic microsomes. 3. Effects of the NADPH-generating system.
    Gram TE; Fouts JR
    J Pharmacol Exp Ther; 1967 Nov; 158(2):317-22. PubMed ID: 4383639
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulation of hepatic microsomal drug-metabolizing enyme systems in primtes byDDT.
    Juchau MR; Gram TE; Fouts JR
    Gastroenterology; 1966 Aug; 51(2):213-8. PubMed ID: 4380264
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of gluconeogenesis and mixed function oxidation.
    Thurman G; Scholz R
    Hoppe Seylers Z Physiol Chem; 1970 Mar; 351(3):294-5. PubMed ID: 4392988
    [No Abstract]   [Full Text] [Related]  

  • 16. An investigation of the decrease in the metabolism of hexobarbital, aminopyrine and p-nitrobenzoic acid by liver from rats bearing a pituitary mammotropic tumor.
    Wilson JT
    J Pharmacol Exp Ther; 1968 Mar; 160(1):179-88. PubMed ID: 5639103
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of a pituitary mammotropic tumor on hepatic microsomal drug metabolism in the rat.
    Wilson JT
    Biochem Pharmacol; 1968 Jul; 17(7):1449-57. PubMed ID: 5690694
    [No Abstract]   [Full Text] [Related]  

  • 18. Species difference in the inhibition of drug metabolism by liver microsomes by different inhibitors.
    Kato R; Onoda K; Takayanagi M
    Jpn J Pharmacol; 1969 Sep; 19(3):438-50. PubMed ID: 4390624
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of morphine treatment and starvation on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Onoda K; Sasajima M
    Jpn J Pharmacol; 1970 Jun; 20(2):194-209. PubMed ID: 4393947
    [No Abstract]   [Full Text] [Related]  

  • 20. Time course differences in the metabolism of drugs by hepatic microsomes from rats, rabbits and mice.
    Gram TE; Fouts JR
    J Pharmacol Exp Ther; 1966 Jun; 152(3):363-71. PubMed ID: 5922307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.